|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-0.89/-1.41
|
企业价值
26.46M
|
资产负债 |
每股账面净值
1.25
|
现金流量 |
现金流量率
--
|
损益表 |
收益
6.77M
|
每股收益
0.92
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/12/24 13:25 EST
同行比较之报价最少15分钟延迟
业务概览
|
|||
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigenfor the treatment of cancer. |